Safety and efficacy of self-expanding metal stents for biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer

Background and study aims Durable biliary drainage is essential during neoadjuvant therapy (NAT) in patients with pancreatic cancer who present with biliary obstruction. Plastic stents (PS) tend to occlude readily, resulting in delay/interruption of treatment. Our aim was to evaluate the safety and...

Full description

Bibliographic Details
Main Authors: Darren D. Ballard, Syed Rahman, Brian Ginnebaugh, Abdul Khan, Kulwinder S. Dua
Format: Article
Language:English
Published: Georg Thieme Verlag KG 2018-05-01
Series:Endoscopy International Open
Online Access:http://www.thieme-connect.de/DOI/DOI?10.1055/a-0599-6190
id doaj-45005873804241b0bbf5c97f778285c0
record_format Article
spelling doaj-45005873804241b0bbf5c97f778285c02020-11-25T02:50:39ZengGeorg Thieme Verlag KGEndoscopy International Open2364-37222196-97362018-05-010606E714E72110.1055/a-0599-6190Safety and efficacy of self-expanding metal stents for biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancerDarren D. Ballard0Syed Rahman1Brian Ginnebaugh2Abdul Khan3Kulwinder S. Dua4Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, U.S.A.Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, U.S.A.Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, U.S.A.Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, U.S.A.Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI, U.S.A.Background and study aims Durable biliary drainage is essential during neoadjuvant therapy (NAT) in patients with pancreatic cancer who present with biliary obstruction. Plastic stents (PS) tend to occlude readily, resulting in delay/interruption of treatment. Our aim was to evaluate the safety and efficacy of self-expanding metal stents (SEMS) for biliary drainage in patients receiving NAT for pancreatic cancer. Patients and methods From 2009 to 2014, all consecutive patients with resectable pancreatic cancer at one tertiary center had SEMS placed for biliary drainage before NAT was started. Data on biliary drainage efficacy, stent malfunction rates and procedural adverse events were collected. Results One hundred forty-two consecutive patients with pancreatic cancer (mean age 66 ± 9 SD years; 81 male, 61 female; 67 resectable, 75 borderline resectable) were enrolled. Eight-seven patients (61 %) had prior PS exchanged to SEMS and 55 (39 %) had SEMS placed upfront. Median duration from SEMS placement to the end of NAT/surgery was 111 days (range 44 – 282). During NAT, SEMS malfunction requiring reintervention occurred in 16 patients (11.2 %): tissue ingrowth 11, stent occlusion from food 6, stent migration 3, incomplete expansion 1, “tissue cheese-cutter” effect 1, and cystic duct obstruction 1. On subgroup analysis, no correlation between SEMS malfunction and stage of disease, prior PS, or duration of NAT was found (r2 = 0.05, P = 0.34). Presence of SEMS in situ did not affect pancreaticoduodenectomy. Conclusion SEMS provide safe, effective and durable biliary drainage during NAT for pancreas cancer. Previously placed PS can be exchanged for SEMS. SEMS do not require removal prior to surgery. Meeting presentations: Digestive Disease Week 2015 and 2017http://www.thieme-connect.de/DOI/DOI?10.1055/a-0599-6190
collection DOAJ
language English
format Article
sources DOAJ
author Darren D. Ballard
Syed Rahman
Brian Ginnebaugh
Abdul Khan
Kulwinder S. Dua
spellingShingle Darren D. Ballard
Syed Rahman
Brian Ginnebaugh
Abdul Khan
Kulwinder S. Dua
Safety and efficacy of self-expanding metal stents for biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer
Endoscopy International Open
author_facet Darren D. Ballard
Syed Rahman
Brian Ginnebaugh
Abdul Khan
Kulwinder S. Dua
author_sort Darren D. Ballard
title Safety and efficacy of self-expanding metal stents for biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer
title_short Safety and efficacy of self-expanding metal stents for biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer
title_full Safety and efficacy of self-expanding metal stents for biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer
title_fullStr Safety and efficacy of self-expanding metal stents for biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer
title_full_unstemmed Safety and efficacy of self-expanding metal stents for biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer
title_sort safety and efficacy of self-expanding metal stents for biliary drainage in patients receiving neoadjuvant therapy for pancreatic cancer
publisher Georg Thieme Verlag KG
series Endoscopy International Open
issn 2364-3722
2196-9736
publishDate 2018-05-01
description Background and study aims Durable biliary drainage is essential during neoadjuvant therapy (NAT) in patients with pancreatic cancer who present with biliary obstruction. Plastic stents (PS) tend to occlude readily, resulting in delay/interruption of treatment. Our aim was to evaluate the safety and efficacy of self-expanding metal stents (SEMS) for biliary drainage in patients receiving NAT for pancreatic cancer. Patients and methods From 2009 to 2014, all consecutive patients with resectable pancreatic cancer at one tertiary center had SEMS placed for biliary drainage before NAT was started. Data on biliary drainage efficacy, stent malfunction rates and procedural adverse events were collected. Results One hundred forty-two consecutive patients with pancreatic cancer (mean age 66 ± 9 SD years; 81 male, 61 female; 67 resectable, 75 borderline resectable) were enrolled. Eight-seven patients (61 %) had prior PS exchanged to SEMS and 55 (39 %) had SEMS placed upfront. Median duration from SEMS placement to the end of NAT/surgery was 111 days (range 44 – 282). During NAT, SEMS malfunction requiring reintervention occurred in 16 patients (11.2 %): tissue ingrowth 11, stent occlusion from food 6, stent migration 3, incomplete expansion 1, “tissue cheese-cutter” effect 1, and cystic duct obstruction 1. On subgroup analysis, no correlation between SEMS malfunction and stage of disease, prior PS, or duration of NAT was found (r2 = 0.05, P = 0.34). Presence of SEMS in situ did not affect pancreaticoduodenectomy. Conclusion SEMS provide safe, effective and durable biliary drainage during NAT for pancreas cancer. Previously placed PS can be exchanged for SEMS. SEMS do not require removal prior to surgery. Meeting presentations: Digestive Disease Week 2015 and 2017
url http://www.thieme-connect.de/DOI/DOI?10.1055/a-0599-6190
work_keys_str_mv AT darrendballard safetyandefficacyofselfexpandingmetalstentsforbiliarydrainageinpatientsreceivingneoadjuvanttherapyforpancreaticcancer
AT syedrahman safetyandefficacyofselfexpandingmetalstentsforbiliarydrainageinpatientsreceivingneoadjuvanttherapyforpancreaticcancer
AT brianginnebaugh safetyandefficacyofselfexpandingmetalstentsforbiliarydrainageinpatientsreceivingneoadjuvanttherapyforpancreaticcancer
AT abdulkhan safetyandefficacyofselfexpandingmetalstentsforbiliarydrainageinpatientsreceivingneoadjuvanttherapyforpancreaticcancer
AT kulwindersdua safetyandefficacyofselfexpandingmetalstentsforbiliarydrainageinpatientsreceivingneoadjuvanttherapyforpancreaticcancer
_version_ 1724737383064141824